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Abstract
To identify novel transmembrane and secretory molecules expressed in cardiac myocytes, signal sequence trap screening
was performed in rat neonatal cardiac myocytes. One of the molecules identified was a transmembrane protein, prostatic
androgen repressed message-1 (PARM-1). While PARM-1 has been identified as a gene induced in prostate in response to
castration, its function is largely unknown. Our expression analysis revealed that PARM-1 was specifically expressed in hearts
and skeletal muscles, and in the heart, cardiac myocytes, but not non-myocytes expressed PARM-1. Immunofluorescent
staining showed that PARM-1 was predominantly localized in endoplasmic reticulum (ER). In Dahl salt-sensitive rats, high-
salt diet resulted in hypertension, cardiac hypertrophy and subsequent heart failure, and significantly stimulated PARM-1
expression in the hearts, with a concomitant increase in ER stress markers such as GRP78 and CHOP. In cultured cardiac
myocytes, PARM-1 expression was stimulated by proinflammatory cytokines, but not by hypertrophic stimuli. A marked
increase in PARM-1 expression was observed in response to ER stress inducers such as thapsigargin and tunicamycin, which
also induced apoptotic cell death. Silencing PARM-1 expression by siRNAs enhanced apoptotic response in cardiac
myocytes to ER stresses. PARM-1 silencing also repressed expression of PERK and ATF6, and augmented expression of CHOP
without affecting IRE-1 expression and JNK and Caspase-12 activation. Thus, PARM-1 expression is induced by ER stress,
which plays a protective role in cardiac myocytes through regulating PERK, ATF6 and CHOP expression. These results
suggested that PARM-1 is a novel ER transmembrane molecule involved in cardiac remodeling in hypertensive heart
disease.
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Introduction
Chronic heart failure is a major and increasing public health
problem, especially in industrialized societies with aging popula-
tions. The rate of hospital admission has increased progressively
over the past years, making heart failure one of the most common
indications for hospital admission in elderly people [1]. Consid-
erable therapeutic advances including pharmacotherapy such as
blockade of renin-angiotensin system and b adrenergic receptor,
and nonpharmacologic therapies such as heart transplantation and
resynchronization therapy have been made in recent years.
However, mortality among patients with heart failure remains
still substantial, and the well-beings deteriorate dramatically,
underscoring the need for additional therapeutic options [2]. Since
there may be significant potential in therapies targeting the novel
pathological pathways, it is crucial to understand the molecular
mechanisms involved in cardiac pathophysiology, especially ones
specifically operated in the hearts.
Apoptosis is a process of innate cellular death, controlled by
complex and diverse molecular mechanisms with considerable cell
type specificity. Apoptosis plays important roles in various aspects
of biology from development to a wide range of diseases such as
cancers and cardiovascular diseases. In the heart, apoptosis is
essential for cardiac development such as formation of cardiac
valves and outflow tract [3]. Although apoptosis is rare in normal
human hearts, the rate of cardiac myocyte apoptosis can increase
several hundred fold in dilated and ischemic cardiomyopathies,
hypertensive heart disease and arrhythmogenic right ventricular
dysplasia, and an association between apoptosis, cardiac myocyte
loss, ventricular remodeling and deterioration of systolic perfor-
mance has been demonstrated in multiple experimental models
[4,5]. Although apoptotic processes are tightly regulated by
extracellular factors and intracellular signalings, the precise
molecular mechanisms governing cardiac myocyte apoptosis have
not been fully elucidated, and understanding the regulation of
apoptosis is of great importance for the advancement of cardiac
biology and for developing novel therapeutic strategies.
In this study, we sought to identify a novel molecule involved in
cardiac pathophysiology using efficient signal sequence trap
method. Signal sequence trap is a strategy to specifically clone
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9746cDNA fragments with signal sequence, a short hydrophobic
stretch of amino acids which mediates targeting of secreted and
cell-surface proteins to the cell membrane [6,7]. As secreted and
membrane molecules play critical roles in cellular functions and
interactions, and are potential therapeutic targets for antagonistic
or agonistic strategies, this strategy could be useful to identify novel
molecules involved in cardiac pathophysiology. Among the
molecules identified, in this study, we analyzed the role of
prostatic androgen repressed message-1 (PARM-1) [8] in cardiac
myocytes.
Results
Identification of PARM-1 as an endoplasmic reticulum
protein expressed in cardiac myocytes
In this study, we applied the efficient signal sequence trap
cloning using retrovirus-mediated gene transfer to identify novel
transmembrane and secreted molecules expressed in cardiac
myocytes [6,9]. Among the molecules identified (Table 1), a
transmembrane protein, PARM-1, was selected for further
analysis, because its expression and functions in cardiac myocytes
were largely unknown. Our expression analysis revealed that
PARM-1 was most abundantly expressed in hearts (Fig. 1A).
PARM-1 was also expressed in skeletal muscles and stomachs.
These results suggested that PARM-1 could be expressed in
striated and smooth muscles. To identify a cell type expressing
PARM-1 in the hearts, we separated cardiac myocytes and non-
myocytes from neonatal hearts, and expression of PARM-1 in
cardiac myocytes and non-myocytes was analyzed. As shown in
Fig. 1B, PARM-1 transcript was specifically expressed in cardiac
myocytes, but not in non-myocytes, indicating that the major
source of PARM-1 in the hearts is cardiac myocytes. To evaluate
how PARM-1 expression is regulated during heart development,
we analyzed mRNA expression in hearts of embryos, neonates and
adult mice (Fig. 1C). PARM-1 mRNA expression in the heart was
detected at embryonic day 10.5 (E10.5), increased until neonatal
stages and, thereafter remained unchanged through adult stages.
To assess subcellular localization of PARM-1 in cardiac myocytes,
flag-tagged PARM-1 was expressed in cultured neonatal cardiac
myocytes, and the cells were stained with anti-flag antibody.
Table 1. Signal sequence trap screening of cultured neonatal cardiac myocytes.
Symbol protein name clone number
Spark secreted acidic cysteine rich glycoprotein 33
Nppa natriuretic peptide precursor type A 13
Tmem9 transmembrane protein 9 (predicted) 10
Coll8a1 procollagen, type XVIII, alpha 1 10
Podxl podocalyxin-like 8
Gpc1 glypican 1 6
Fxyd5 FXYD domain-containing ion transport regulator 5 5
Parm1 prostatic androgen repressed message 1 5
Col4a1 procollagen, type IV, alpha 2 (predicted) 4
Col1a1 procollagen, type 1, alpha 1 4
Srl sarcalumenin 4
Sdc3 syndecan 3 4
Jun Jun oncogene 3
Dlk1 delta-like 1 homolog (Drosophila) 3
Igfbp3 insulin-like growth factor binding protein 3 3
Col4a2 procollagen, type IV, alpha 1 2
Pi16 protease inhibitor 16 (predicted) 2
Notch3 Notch gene homolog 3 2
Tmem9 sf4 transmembrane 9 superfamily protein member 4 1
RGD1562476 similar to Eso3 protein (predicted) 1
Pecam platelet/endothelial cell adhesion molecule 1
Gnai2 guanine nucleotide binding protein, alpha inhibiting 2 1
Sparcl1 SPARC-like 1 1
Atp6ap2 ATPase, H+ transporting, lysosomal accessory protein 2 1
Myadm myeloid-associated differentiation marker 1
Apoe apolipoprotein E 1
Fstl1 follistatin-like 1 1
Hspa5 heat shock 70 kDa protein 5 (glucose-regulated protein) 1
Sfrp1 secreted frizzled-related protein 1 1
Cd320 CD320 antigen 1
Canx Calnexin 1
doi:10.1371/journal.pone.0009746.t001
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PLoS ONE | www.plosone.org 2 March 2010 | Volume 5 | Issue 3 | e9746Figure1.PARM-1isan ERproteinexpressedin cardiac myocytes.A,B, C: PARM-1 expression was assessedbykinetic real-timeRT-PCRin various
tissues of adult mice (A), cultured rat neonatal cardiac myocytes and non-myocytes (B), and developmental mouse hearts (C), respectively. *P,0.05
versus cardiac myocytes (B) or embryonic hearts (C). D: Cellular localization of PARM-1 was analyzed by immunostaining of cultured neonatal rat cardiac
myocytes expressing flag-tagged PARM-1 with anti-Flag antibody (left), and anti-GRP78 antibody or MitoTacker (center). Nuclei were stained by DAPI.
doi:10.1371/journal.pone.0009746.g001
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with intense perinuclear localization (Fig. 1D). When the cells
were co-stained with anti-78 kDa glucose regulated protein/BiP
(GRP78) antibody or MitoTracker, PARM-1 was co-localized
with GRP78, an endoplasmic reticulum (ER)-resident chaperone,
but not with MitoTracker, a mitochondrion-selective dye (Fig.
1D). Thus, PARM-1 is a transmembrane protein predominantly
localized in ER in cardiac myocytes.
PARM-1 expression is increased in hearts of hypertensive
heart disease
To investigate whether PARM-1 expression was regulated
under pathological conditions in the postnatal hearts, we analyzed
PARM-1 expression in the hearts of Dahl salt-sensitive rats. Dahl
salt-sensitive rats were randomly assigned to receive either a 0.3%
NaCl (low-salt) diet or an 8% NaCl (high-salt) diet at the age of 6
weeks. Consistent with the previous reports [10,11], upon a high-
salt diet, Dahl salt-sensitive rats developed systemic hypertension,
and a subsequent increase in left ventricular weight (LVW) to body
weight (BW) ratio until 4 weeks after starting diet (Fig. 2A),
indicating the development of left ventricular hypertrophy.
Thereafter, a significant increase in lung weight (LW) to BW
ratio and atrial weight (AW) to BW ratio was observed at 8 weeks
(Fig. 2A), which was concomitant with a marked increase in atrial
natriuretic factor (ANF) expression (Fig. 2B), suggesting the
transition from hypertrophy to heart failure. In this model,
PARM-1 expression was significantly increased at 8 weeks after
starting diet, and reached more than 5 fold increase at 12 weeks
(Fig. 2B). As ER stress is recently implicated in the pathogenesis of
heart diseases such as ischemic heart disease and heart failure
[12,13], we analyzed the expression of ER stress markers such as
GRP78 and C/EBP homologous protein transcription factor
(CHOP) in this model, and found that these ER stress markers
were induced at the phase of transition from hypertrophy to heart
failure (Fig. 2C).
Inflammatory cytokines and ER stress augment PARM-1
expression in cardiac myocytes
To explore how PARM-1 expression was regulated, cultured
cardiac myocytes were stimulated by various hypertrophic stimuli
or cytokines, and PARM-1 expression was analyzed by real time
PCR. As shown in Fig. 3A, PARM-1 expression was stimulated by
proinflammatory cytokines such as TGF-b, TNF-a and IL-1b, but
not by hypertrophic stimuli such as phenylephrine, leukemia
inhibitory factor and isoproterenol. Since ER stress developed in
hypertensive heart failure (Fig. 2C), we also analyzed PARM-1
expression in ER stress conditions (Fig. 3B). Both thapsigargin and
tunicamycin treatments led to induction of GRP78 and CHOP in
cardiac myocytes. PARM-1 expression was markedly increased
24 hours after treatment with these ER stress inducers, and
continued to be increased up to 48 hours (Fig. 3B). While
thapsigargin and tunicamycin increased PARM-1 expression in a
dose-dependent manner in cardiac myocytes, neither of them
induced PARM-1 expression in cardiac fibroblasts (Fig. 3B),
indicating PARM-1 induction by ER stress is also specific for
cardiac myocytes. Treatment with thapsigargin and tunicamycin
resulted in reduced viability in cardiac myocytes, and the effects
were time- and dose-dependent (Fig. 3C).
Silencing PARM-1 augments apoptotic cell death
induced by ER stress
To assess functional significance of PARM-1 induction in
response to ER stress, PARM-1 expression was silenced by siRNA.
We identified three different siRNAs, which efficiently silenced
PARM-1 expression in cardiac myocytes (Fig. 4A). When PARM-
1 expression was silenced by siRNA, ER stress-induced apoptotic
response was significantly increased compared to control siRNA
(Fig. 4B). Silencing PARM-1 expression further reduced cell
viability in response to ER stress inducers. These results indicated
that increased expression of PARM-1 in response to ER stress has
a protective role in cardiac myocytes.
PARM-1 silencing decreases PERK and ATF6, and
increases CHOP expression in ER stress condition
In the last set of experiments, we analyzed the effects of PARM-
1 silencing on the signal transduction pathways mediating ER
stress responses. In ER stress/unfolded protein response (UPR),
misfolded proteins are first recognized by ER-resident chaperons
such as GRP78. The status of protein folding in ER lumen is then
sensed and transduced by three ER membrane proteins, PKR-like
endoplasmic reticulum kinase (PERK), activating transcription
factor 6 (ATF6) and endoribonuclease inositol-requiring enzyme-1
(IRE-1), each of which defines a distinct arm of ER stress responses
[12,13,14]. Expression of GRP78, ATF6 and IRE-1, phosphor-
ylation of PERK and mRNA splicing of XBP-1 were induced by
ER stress inducers, thapsigargin or tunicamycin, in cardiac
myocytes (Fig. 5A). Although silencing PARM-1 expression did
not change GRP78 and IRE-1 expression, and XBP-1 splicing,
expression of PERK and ATF6, and phosphorylation of PERK
were markedly attenuated by PARM-1 silencing, only in the
settings of ER stress (Fig. 5A). It has been shown that ER stress-
induced apoptosis signal is mediated by increased expression of
CHOP, and activation of Caspase-12 and c-Jun NH2-terminal
kinase (JNK) [12,13,14]. While silencing of PARM-1 expression
did not alter JNK and Caspase-12 activation, CHOP expression
by ER stress inducers was significantly enhanced by PARM-1
silencing (Fig. 5B).
Discussion
In this study, we carried out the efficient signal sequence trap
cloning using retrovirus-mediated gene transfer [6,9] to identify
novel transmembrane and secreted molecules expressed in cardiac
myocytes. Through this screening, several genes, which have not
been widely recognized to be expressed in cardiac myocytes, were
identified. These include PARM-1, glypican-1, podocalyxin-like
and CD320 antigen, and our expression analysis verified that these
genes were indeed expressed in cardiac myocytes (data not shown).
As PARM-1 expression was most significantly modulated in the
hearts of hypertensive heart disease model of Dahl salt-sensitive
rats, we focused PARM-1 in this study. While changes in
expression of other genes were not as marked as PARM-1 in
this model (data not shown), changes in expression level could not
designate the biological significance, and the roles of these other
gene products in cardiac myocytes will be an important issue to be
studied in the future studies.
PARM-1, also referred to as castration induced prostatic
apoptosis-related protein 1 (Cipar1), is originally identified as a
gene overexpressed in the prostate of castrated rats [8]. PARM-1 is
expressed in the epithelial cells of involuting rat prostates after
androgen removal, and the regulation of PARM-1 by androgen is
limited to the prostates [8]. In contrast, in prostate cancer cell
lines, and in human prostate cancer xenograft, CWR22, PARM-1
is constitutively expressed, and PARM-1 expression is positively
regulated by androgen in CWR22 xenograft [15]. While the
kinetics of PARM-1 expression is highly correlated with the
development of apoptosis after castration, transient expression of
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PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9746PARM-1 does not induce programmed cell death [8]. Although
ectopic expression of human PARM-1 in a prostate cancer cell line
results in increased colony formation [15], suggesting a probable
role of PARM-1 in cell proliferation, the others reported that
transient expression of rat PARM-1 does not alter the proliferative
property of another prostate cancer cell line [16]. Thus, the
Figure 2. PARM-1 expression and ER stress response was activated in hypertensive heart disease model of Dahl salt-sensitive rats.
A: The animals were subjected to a high- (8% NaCl, n=12 for each time point) or low-salt diet (0.3% NaCl, n=8 for each time point). Blood pressure
and left ventricular weight (LVW), Body weight (BW), lung weight (LW) and atrial weight (AW) were measured at the indicated periods of time after
starting the designated diet. B, C: ANF and PARM-1 expression (B), and ER stress markers such as GRP78 and CHOP (C) were analyzed by kinetic real-
time PCR on cDNAs from the hearts of Dahl salt-sensitive rats. *P,0.05 versus a low-salt diet group at the respective time point.
doi:10.1371/journal.pone.0009746.g002
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PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9746Figure 3. PARM-1 expression was induced by inflammatory cytokines and ER stress inducers specifically in cardiac myocytes. A:
Cultured rat neonatal cardiac myocytes were stimulated by hypertrophic stimuli such as 100 mmol/l phenylephrine (PE), 1000 U/ml leukemia
inhibitory factor (LIF) and 10 mmol/l isoproterenol (ISP), or inflammatory cytokines such as 100 ng/ml TNF-a, 5 ng/ml IL-1b and 4 ng/ml TGF-b. PARM-
1 expression was analyzed 48 hours after stimulation. B: Cardiac myocytes were treated with 0.5 mmol/l thapsigargin (TG) or 0.1 mg/ml tunicamycin
(TM) for the indicated periods of time, and GRP78, CHOP and PARM-1 expression was analyzed by kinetic real time PCR. C: Cardiac myocytes and
fibroblasts were treated with TG or TM for 48 hours at the indicated concentration, and PARM-1 expression was analyzed. D: Cardiac myocytes were
treated with TG or TM as indicated, and cell viability was assessed by WST-8 assay. *P,0.05 versus non-treated control cells.
doi:10.1371/journal.pone.0009746.g003
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PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9746Figure 4. Silencing of PARM-1 augmented apoptotic response to ER stress. A: Cultured neonatal rat cardiac myocytes were transfected with
30 nmol/l of three different siRNA duplexes, and assessed for PARM-1 expression 24 hours after transfection. B: Cells were treated with TG or TM
72 hours after transfection with siRNAs for 24 hours. Apoptotic cell death was assessed by TUNEL assay, and cell viability was analyzed by WST-8
assay. *P,0.05 versus control siRNA (Si cont).
doi:10.1371/journal.pone.0009746.g004
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and its roles are largely unknown.
Our analysis on hypertensive heart disease model of Dahl salt-
sensitive rats demonstrated that PARM-1 expression was
significantly upregulated following a high-salt diet. While one of
the early cardiac manifestations of this model is hypertension-
induced cardiac hypertrophy [10,11], PARM-1 expression was
unchanged 4 weeks after starting a high-salt diet, when a
significant increase in LVW to BW ratio was already detected
(Fig. 2A,B). Further, in cultured cardiac myocytes, stimulation
with hypertrophic stimuli did not alter the expression of PARM-1
(Fig. 3A). This could be in accordance with PARM-1 expression
in the hearts during normal developmental stages. While a
common feature of various hypertrophic responses is re-
activation of fetal gene programs such as ANF and skeletal a-
actin genes [17], PARM-1 expression readily detectable at E10.5
was increased toward neonatal stages, and then maintained
through adult stages (Fig. 1C). These results suggested that
PARM-1 expression could not be a part of fetal gene programs or
hypertrophic responses. Another feature of hypertensive heart
disease is a development of heart failure. In our model, 8 weeks
after staring a high-salt diet, a significant increase in LW to BW
ratio was observed, indicating the presence of lung congestion.
Although we did not detected a significant increase in LV
dimension and a decrease in fractional shortening up to 12 weeks
of a high-salt diet (data not shown), a significant increase in AW
to BW ratio was noted at 8 weeks, suggesting the development of
diastolic heart failure in this model. In this model, PARM-1 was
significantly upregulated 8 weeks after starting a high-salt diet,
suggesting that PARM-1 was induced in the setting of heart
failure. Development of heart failure involves neurohumoral and
inflammatory mechanisms [18,19], and recent evidences have
suggested that ER stress plays an important role in the
pathogenesis of heart failure [12,13]. In cultured cardiac
myocytes, inflammatory cytokines stimulated PARM-1 expres-
sion (Fig. 3A). Further, ER stress inducers, thapsigargin and
tunicamycin markedly upregulated PARM-1 expression (Fig. 3B),
and ER stress markers such as GRP78 and CHOP were also
upregulated in the hearts of hypertensive heart disease model at
the heart failure phase (Fig. 2C). These results implied that
PARM-1 expression is upregulated during heart failure, involving
inflammatory cytokines and ER stress.
Figure 5. PARM-1 silencing decreases PERK and ATF6, and increases CHOP expression in ER stress condition. Cultured neonatal rat
cardiac myocytes were transfected with siRNAs, and, after 72 hours, were treated with TM or TG for 48 hours. A: Immunoblot analysis was performed
with antibody against GRP78, phospho-PERK, PERK, ATF6, IRE-1 or GAPDH. XBP-1 mRNA splicing was assessed by PCR. B: Immunoblot analysis was
performed with antibody against CHOP, Caspase-12, phospho-JNK, JNK or GAPDH. C: Densitometric analysis was carried out using ImageJ software.
The results were normalized against GAPDH, and expressed as percentages of the maximum. *P,0.05 versus control siRNA (Si cont) of respective
treatment with TM or TG.
doi:10.1371/journal.pone.0009746.g005
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stress induced PARM-1 expression, PARM-1 could play a role in
ER stress response. ER is a cellular organelle, where protein
synthesis and folding of secreted and transmembrane proteins take
place. When ER environment is perturbed, and the folding of
nascent proteins is impaired, a quality control system called UPR
is activated [12,13,14]. Initially, UPR is an adaptive response in
which the cells attempt to overcome the accumulation of mis-
folded proteins through augmenting protein folding capacity.
However, when ER stress is excessive and prolonged, cells
undergo apoptotic cell death. Thus, ER stress response has a
conditional ability to protect the cells or activate cell death
program. In the hearts, ER stress response has been shown to be
activated in several pathological models including myocardial
infarction, ischemia/reperfusion and pressure overload-induced
hypertrophy [20,21,13,22]. Pressure overload by transverse aortic
constriction has been shown to induce prolonged ER stress during
the transition from cardiac hypertrophy to heart failure [20].
AMP-activated protein kinase protects cardiac myocytes from
hypoxic injury by attenuating ER stress [23]. Aberrant ER quality
control in transgenic mice with mutant KDEL receptor, or
chronic myocardial inflammation induced by chemoattractant
protein-1 transgene activates ER stress response and causes heart
failure [24,25]. These results indicated that ER stress response
could be deleterious in the hearts. In contrast, overexpression of
ER stress gene GRP94 protects cardiac myocytes from oxidative
injury [26], and inducible transgene of activated form of ATF6 in
the hearts protects the hearts from ischemia/reperfusion damage
[27], suggesting the protective role of ER stress response in the
hearts. Thus, the outcome of ER stress response is also context
dependent in the heart. In our model of hypertensive heart disease,
ER stress response assessed by the expression of GRP78 and
CHOP was activated in the phase of transition from hypertrophy
to heart failure (Fig. 2C). While GRP78 expression reached a peak
at 8 weeks of diet and then declined, CHOP expression remained
upregulated until 12 weeks. Those expression patterns might be
compatible with those reported in transverse aortic constriction-
induced heart failure model, as a peak expression of GRP78 is
observed at 1 week after transverse aortic constriction, while
CHOP is upregulated even at 4 weeks [20]. Since induction of ER
chaperone GRP78 represents a major survival arm of ER stress
response, and indeed, overexpression of ER chaperone is
protective for cardiac myocytes from ischemia and calcium
overload injuries [26], these observations could be in good
accordance with the general view that the UPR has a protective
role during initial phase of ER stress, while proapoptotic pathways
are activated upon continued ER stress [12,13,14]. Thus, ER
stress response in our model might have the deleterious effect in
the transition to heart failure, while it is still possible that this ER
stress response was a part of counteracting efforts against
developing heart failure.
Consistent with the contradictory roles of ER stress response in
cell survival and death, ER stress has been demonstrated to
activate both prosurvival and apoptotic signaling pathways
[13,14]. In cultured cardiac myocytes, treatment of cardiac
myocytes with ER stress inducers resulted in reduced viability
and increased apoptotic cell death [20]. In this setting, PARM-1
expression was markedly increased (Fig. 3B), and silencing PARM-
1 expression significantly augmented ER stress-induced cell death
(Fig. 4B), indicating PARM-1 is a part of cell survival pathways in
ER stress response. Given that PARM-1 expression was induced in
the phase of transition to heart failure in hypertensive heart disease
model of Dahl salt-sensitive rats (Fig. 2B), the increased expression
of PARM-1 in this model could play a role to counteract against
development of heart failure through inhibiting apoptosis of
cardiac myocytes, although further studies are needed to
determine the role of PARM-1 induction in the development of
heart failure in vivo.
ER stress is sensed by three distinct ER sensory proteins, PERK,
ATF6 and IRE-1, which are kept inactivated by binding with ER-
resident chaperones such as GRP78 and GRP94. Upon
accumulation of misfolded proteins in ER, the chaperones are
occupied by misfolded proteins, which results in the release and
activation of the ER stress sensors, and subsequent activation of
downstream signaling pathways [12,13,14]. The downstream
signaling effectors include prosurvival and proapoptotic pathways,
and it is anticipated that the balance between prosurvival and
proapoptotic pathways determines the ultimate outcome of ER
stress response, while the precise molecular mechanisms involved
in cell fate determination remain to be delineated. In this study,
silencing of PARM-1 did not alter the expression of GRP78,
suggesting the expression of PARM-1 was not involved in the
regulation of ER stress itself, or expression of ER chaperones (Fig.
5A). Downregulation of PARM-1 expression by siRNA markedly
attenuated the expression of PERK and ATF6 without affecting
IRE1 induction and XBP-1 splicing. Interestingly, these effects of
PARM-1 silencing on PERK and ATF6 expression were only
observed upon stimulation with thapsigargin or tunicamycin (Fig.
5). These results suggested that PARM-1 plays a crucial role in
maintaining PERK and ATF6 expression in the setting of ER
stress conditions. Since overall PERK signaling is protective
against cell death in most circumstances [13,14,28], and
preactivation of ATF6 protects the heart against ischemia/
reperfusion insult [27], maintenance of PERK and ATF6
expression by PARM-1 is critical for cardiac myocytes to cope
with ER stresses. The CHOP, JNK and Caspases are distal
effectors of ER stress response that have been implicated in
mediating apoptotic signals. CHOP induction was markedly
augmented by PARM-1 silencing, while activation of JNK and
Caspase-12 was unaffected (Fig. 5B,C), indicating that PARM-1
was also mediating prosurvival effect by suppressing CHOP-
mediated apoptotic pathways in cardiac myocytes. Expression of
CHOP, but not activation of JNK and Caspase-12 has been
shown to be induced by transverse aortic constriction in murine
hearts [20]. In cultured cardiac myocytes, proteasome inhibitors
are shown to activate ER stress response and apoptosis, in which
silencing CHOP, but not inhibition of JNK or Caspase-12 rescues
cardiac myocytes from apoptosis [29]. Thus, CHOP expression
might be one of important mechanisms inducing cardiac myocyte
apoptosis in response to ER stress, and PARM-1 has an inhibitory
role in this pathway. As CHOP is known to be regulated
downstream of PERK and ATF-6 [30,13,28], and PARM-1 is
involved in the maintenance of PERK and ATF-6 without
affecting IRE-1 induction and XBP-1 splicing, it looks likely that
PARM-1 is involved in a specific set of signal transduction
pathways in ER stress response, while further studies are clearly
needed to delineate the molecular mechanisms by which PARM-1
regulates ER stress response pathways.
An intriguing finding of this study was PARM-1 expression and
induction of PARM-1 by ER stress was specific for cardiac
myocytes (Fig. 3B). Recently, several ER membrane molecules
specific for certain cell types have been identified. Those include
CREB4, CREB-H, Luman and OASIS, and are involved in ER
stress response [31,32,33,34]. For example, CREB-H is expressed
exclusively in the liver [35], and activated by ER stress [34].
However, ER stress-induced activation of CREB-H leads to
induction of acute phase response genes such as C-reactive protein
and serum amyloid P-component rather than canonical unfolded
The Role of PARM-1 in Hearts
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specialized roles in specialized cells. Although there is a striking
difference between those molecules and PARM-1, as those belong
to basic-leucine zipper transcription factor, and PARM-1 does not
have any known domain for transcription factors, PARM-1 could
mediate ER stress response specific for cardiac myocytes.
In this study, we identified PARM-1 as an ER protein
specifically expressed in cardiac myocytes, and found that
PARM-1 expression was induced in hypertensive heart disease
model, and by ER stress in cardiac myocytes. Further, it was also
shown that PARM-1 had a protective role against ER stress-
induced apoptotic response in cardiac myocytes. As elucidation of
cardiac specific ER stress response could have therapeutic impacts
on many heart diseases, identification of molecular mechanisms
regulated by PARM-1 will be an important issue to understand
cardiac specific ER stress responses.
Materials and Methods
Cardiac myocytes culture
Neonatal rat cardiac myocytes and non-myocytes were
prepared from 1-day-old Wistar rat hearts as described previously
[36,37]. Neonatal rat ventricles were enzymatically digested, and
cardiac myocytes were purified over a discontinuous Percoll
gradient. Cardiac myocytes were cultured in DMEM/F-12
medium supplemented with 5% fetal bovine serum and
100 mmol/l 5-bromo-2-deoxyuridine (BrdU) for 16-24 hours,
and culture medium was then changed to serum-deprived medium
containing insulin, transferrin, selenium, bovine serum albumin
and BrdU. Non-myocytes in the upper layer were plated onto non-
coated culture dishes, and the attached cells were cultured and
passaged. Non-myocytes at 2nd passage were used for the
experiments. Each experiment was performed under serum free
condition at least 24 hrs after serum deprivation.
Signal sequence trap
Signal sequence trap by retrovirus-mediated expression screen-
ing (SST-REX) was performed as previously described [6,9].
Briefly, a library was constructed in the retrovirus vector pMX-
SST employing cDNA derived from poly(A)
+ RNA isolated from
neonatal rat cardiac myocytes. The interleukin-3 (IL-3)-dependent
pro-B cell line Ba/F3 [6,9] was infected with retrovirus, followed
by seeding onto 96-multiwell plates in the absence of IL-3.
Genomic DNA extracted from IL-3-independent Ba/F3 clones
were subjected to PCR to recover the integrated cDNAs using
primers specific for the cloning vector. After electrophoresis of the
PCR products, DNA was recovered and subjected to sequencing.
Animals and treatments
Male Dahl salt-sensitive rats (6 weeks old) were purchased from
Shimizu laboratory supplies. From 6 weeks onwards, these rats
were fed a high-sodium diet (containing 8% NaCl) or a low-
sodium diet (containing 0.3% NaCl) [10,11]. After 2, 4, 8 and 12
weeks, blood pressure was measured by the tail-cuff method. All
procedures using animals performed in this study were approved
by the Institutional Animal Care and Use Committee of Kyoto
Prefectural University of Medicine.
Reverse transcriptase (RT)-PCR
Total RNA was extracted from rat tissues using TRIzol
(Invitrogen) and from neonatal rat cardiac myocytes using the
RNeasy mini kit (Qiagen), and then cDNA was synthesized by the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Synthesized cDNA was analyzed by quantitative
kinetic real-time PCR using the ABI Prism 7700 Sequence
Detector system (Applied Biosystems) with SYBR Premix Ex Taq
(Takara) [38,39]. Rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was used for normalization, and the comparative
threshold (CT) method was used to assess the relative abundance of
the targets. For XBP-1 mRNA splicing, the primers flanking the
intron splicing site by IRE-1 was used for PCR, and the products
were analyzed by agarose gel electrophoresis with visualization
using ethidium bromide [40].
Immunostaining
Cells were stained with anti-flag M2 monoclonal antibody
(Sigma) or goat polyclonal antibody against GRP78 (Santa Cruz),
followed by Alexa Fluor 488- or Alexa Fluor 555-conjugated
secondary antibody (Invitrogen). Mitochondria were stained with
MitoTracker Green FM (Invitrogen) and nuclei were visualized
using DAPI. Images were captured with a BZ-8000 microscope
(Keyence).
Immunoblot analysis
Cells lysates normalized by protein concentration were
subjected to 10% or 15% SDS-polyacrylamide gel electrophoresis,
and transferred to polyvinylidene difluoride membranes (Milli-
pore) [38,39]. Blots were immunoblotted with the primary
antibody against GRP78, CHOP (Santa Cruz), phospho-PERK,
PERK, IRE-1, phospho-JNK, JNK (Cell Signaling), Caspase-12
(Sigma) or ATF6 (AnaSpec), and horseradish peroxidase-labeled
donkey secondary antibody, followed by enhanced chemilumines-
cence (GE Healthcare). Densitomeric analysis was performed
using ImageJ software.
Small interfering RNA–mediated silencing
PARM-1 stealth siRNA duplexes were purchased from Invitro-
gen. Target sequences of siRNA are: siRNA-1; 59-GAACA-
CAGTCTCGGCAGTCCTGAAA-39, siRNA-2; 59-TCCGCTT-
CCGTTACCTCTAACCACA-39, siRNA-3; 59-GCGGCATA-
TCTGAAGATCAGGCATT-39. Cells were transfected with
30 nmol/L siRNA duplex using Lipofectamine RNAiMAX
reagent (Invitrogen) according to the manufacture’s instruction
[41]. Stealth RNAi negative control (Invitrogen) was used as a
control.
Cell viability and TUNEL assay
Cell viability was assessed using WST-8 (2-(2-methoxy-4-
nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazoli-
um, monosodium salt) (Kishida Kagaku) according to the
manufacturer’s instruction. Apoptotic cells were detected by in
situ terminal deoxynucleotidyl transferase-mediated biotinylated
UTP nick end labeling (TUNEL) assay using ApopTag Red In
Situ Apoptosis Detection Kit (Chemicon) as previously described
[39]. Cells were nuclear stained with DAPI, and the TUNEL
positive and total nuclei were counted under the fluorescent
microscope (IX71, Olympus Corporation) in 5 view fields per
well.
Statistical analysis
All experiments were performed at least three times in
duplicates. Data were expressed as means 6 standard errors and
analyzed by unpaired Student’s t-test for comparisons between two
groups, or one-way ANOVA with post hoc analysis for multiple
comparisons. A value of p,0.05 was considered statistically
significant.
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